Targeting Spreading Depolarization After Chronic Subdural Hematoma Surgery (TASD)

NCT04966546 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Loss of Departmental support

Conditions

Chronic Subdural Hematoma

Interventions

DRUG: Memantine Hydrochloride
DRUG: Placebo

Sponsor

University of New Mexico